Dietary Changes for Psoriatic Arthritis
(DIPSA Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to learn whether changing diet impacts psoriatic arthritis (PsA).
Research Team
Alexis Ogdie-Beatty, MD, MSCE
Principal Investigator
University of Pennsylvania
Lihi Eder, MD, PhD
Principal Investigator
Women's College Hospital, University of Toronto
Eligibility Criteria
This trial is for adults aged 18-80 with a BMI between 25 and 40, diagnosed with Psoriatic Arthritis by a rheumatologist. Participants must have been on stable PsA treatment for at least three months, own a smartphone or be willing to use one provided, and are open to changing their diet for the study duration. Exclusions include eating disorders, certain medical conditions like insulin-dependent diabetes or advanced cancer, food allergies related to the study diets, inability to consent or read/write in English.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Diet 1 (N/A)
- Diet 2 (N/A)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
Dr. Joan Lau
University of Pennsylvania
Chief Executive Officer since 2020
PhD in Neuroscience from the University of Cincinnati College of Medicine, MBA from the Wharton School of Business, BS in Bioengineering from the University of Pennsylvania
Dr. Robert Iannone
University of Pennsylvania
Chief Medical Officer since 2019
MD from Yale University, MSCE from the University of Pennsylvania
Women's College Hospital
Collaborator
Heather McPherson
Women's College Hospital
Chief Executive Officer since 2020
Master of Science in Rehabilitation Science, University of Toronto
Dr. Cindy Maxwell
Women's College Hospital
Chief Medical Officer since 2023
MD, specialization in Maternal Fetal Medicine
NYU Langone Health
Collaborator
Dr. Alec C. Kimmelman
NYU Langone Health
Chief Executive Officer
MD and PhD from Mount Sinai School of Medicine
Dr. Nicole M. Adler
NYU Langone Health
Chief Medical Officer since 2023
MD